IR-Med (IRME) Other Accumulated Expenses (2022 - 2023)
IR-Med recorded quarterly Other Accumulated Expenses of $161000.0 in Q4 2023, up 1.26% quarter-over-quarter from $159000.0 in Q1 2023, and down 0.62% year-over-year from $162000.0 in Q4 2022.
IR-Med's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $161000.0 for Q4 2023.
- In Q4 2023, Other Accumulated Expenses fell 0.62% year-over-year to $161000.0; the TTM figure through Dec 2023 stood at $161000.0 (down 0.62% YoY), while the FY2023 annual figure was $161000.0, down 0.62% from the prior year.
- Other Accumulated Expenses came in at $161000.0 for Q4 2023 at IR-Med, up from $159000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $162000.0 in Q4 2022 to a low of $159000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | IR-Med | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 161,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 162,000.00 |